Science Explorer Back to mapMap
Discussion
Researcher · The Christie NHS Foundation Trust · United Kingdom

Mathew Carter

Mathew Carter publishes mostly in Oncology, Cancer Research and Pulmonary and Respiratory Medicine, on topics such as Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.

OpenAlex
World rank
#187,447
of 7,710,434 ranked researchers
Rank in United Kingdom
#17,029
of 367,258
Works
47
Citations
2.8k
Citations per work
58.7
h-index
18
i10-index 24Top 28% in Oncology
Mathew Carter

What does Mathew Carter research?

Mathew Carter's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (31%).

Health Sciences: 24 works · 50.0% of their workMedicine: 24 works · 50.0% of their workOncology: 12 works · 25.4% of their workPulmonary and Respiratory Medicine: 8 works · 17.2% of their workEpidemiology: 2 works · 3.7% of their workSurgery: 2 works · 3.7% of their workLife Sciences: 15 works · 31.4% of their workBiochemistry, Genetics and Molecular Biology: 15 works · 31.4% of their workCancer Research: 9 works · 18.7% of their workMolecular Biology: 6 works · 12.7% of their workEverything else: 9 works · 18.6% of their workTHEIR WORKMathew Carter47works
Life Sciences31%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2450.0%
    1. Biochemistry, Genetics and Molecular Biology1531.4%
  3. Everything else918.6%
  1. 1Oncology25% of their works
  2. 2Cancer Research19% of their works
  3. 3Pulmonary and Respiratory Medicine17% of their works
  4. 4Molecular Biology13% of their works
  5. 5Surgery4% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Mathew Carter's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Cancer Genomics, Mutational Signatures, ALK Inhibitors, EGFR Mutations, Immunotherapy and Genomic Profiles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy473 topics
  2. Clinical Trials272 topics
  3. Cancer Genomics201 topic
  4. Mutational Signatures201 topic
  5. ALK Inhibitors151 topic
  6. EGFR Mutations151 topic
  7. Immunotherapy152 topics
  8. Genomic Profiles121 topic
  9. Small-Cell Lung Cancer121 topic
  10. Cancer Stem Cells81 topic
  11. Tumor Metastasis81 topic
  12. RNA methylation71 topic
  13. m6A-seq71 topic
  14. Immune Checkpoint Blockade41 topic
  15. Neuroendocrine Tumors41 topic
  16. PD-1 and PD-L141 topic
  17. Pancreatic Neuroendocrine Tumors41 topic
  18. CAR T Cells31 topic
  19. Chimeric Antigen Receptor31 topic

Where does Mathew Carter work?

Mathew Carter's main affiliation in the publication record is The Christie NHS Foundation Trust, United Kingdom.

How many publications and citations does Mathew Carter have?

OpenAlex counts 47 works and 2,760 citations for Mathew Carter, an h-index of 18, ranking #187,447 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mathew Carter. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.